Specializing In
- Kidney Transplant
- Pancreas Transplant
Professional Summary
Education & Certifications
- Fellowship: California Pacific Medical Center (1995) CA
- Residency: University of Montreal (1991) Canada
- Medical Education: University of Montreal (1986) Canada
-
- Internship: University of Montreal (1987) Canada
- Board Certification: American Board of Surgery, General Surgery (1996)
- Board Cerification, American Board of Surgery, General Surgery (1996)
- M. Sc., Mc Gill University, Transplant Immunology (1995)
- ., California Pacific Med Center, Multi-Organ Transplantation (1995)
- FRCSC, University of Montreal, General Surgery (1991)
- MD, Univerty of Montreal (1986)
Administrative Appointments
- Director Adult Kidney and Pancreas Transplant Program, Stanford University School of Medicine (2001 - Present)
- Member, Stanford Diabetes Research Center (2018 - Present)
-
Publications
-
[Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus].
Busque, S., Demers, P., Saint-Louis, G., Boily, J. G., Tousignant, J., Lemieux, F., … Daloze, P. (1999). [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus]. Annales De Chirurgie, 53(8), 687–689. -
Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients
Zaltzman, J., McAlister, V., Russell, D., Halloran, P., Landsberg, D., Busque, S., … Peets, J. (2001). Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1044–1045. -
Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation
Busque, S., Shoker, A., Landsberg, D., McAlister, V., Halloran, P., Shapiro, J., … Schulz, M. (2001). Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1266–1267. -
-
In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil
Morissette, P., Albert, C., Busque, S., St-Louis, G., & Vinet, B. (2001). In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil. THERAPEUTIC DRUG MONITORING, 23(5), 520–525. -
Chest wall and liver resection for chondrosarcoma
Noiseux, N., Ferraro, P., Busque, S., Harris, P., & Duranceau, A. (2002). Chest wall and liver resection for chondrosarcoma. ANNALS OF THORACIC SURGERY, 74(2), 598–598. -
Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: A single center experience
Beaunoyer, M., Busque, S., St-Louis, G., Smeesters, C., Paquet, M. P., Lallier, M., … Daloze, P. (2002). Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: A single center experience. TRANSPLANTATION PROCEEDINGS, 34(5), 1694–1695. -
Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation
JOHNSON, S., Qi, S. J., Xu, D. S., Jolicoeur, M., Liu, D. Y., Barama, A., … Chen, H. F. (2003). Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation. MICROSURGERY, 23(5), 476–482. -
Preoperative renal volumes as a predictor of graft function in living donor transplantation
Saxena, A. B., Busque, S., Arjane, P., Myers, B. D., & Tan, J. C. (2004). Preoperative renal volumes as a predictor of graft function in living donor transplantation. AMERICAN JOURNAL OF KIDNEY DISEASES, 44(5), 877–85. -
A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients
Zaltzman, J. S., Boucher, A., Busque, S., Halloran, P. F., Landsberg, D. N., McAlister, V. C., … Ferguson, R. (2005). A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients. CLINICAL TRANSPLANTATION, 19(1), 26–32. -
Conversion of stable liver transplant recipients from a twice-daily prograf-based regimen to a once-daily modified release tacrolimus-based regimen
Florman, S., Alloway, R., Kalayoglu, M., Lake, K., Bak, T., Klein, A., … First, M. R. (2005). Conversion of stable liver transplant recipients from a twice-daily prograf-based regimen to a once-daily modified release tacrolimus-based regimen. TRANSPLANTATION PROCEEDINGS, 37(2), 1211–1213. -
Treatment of hepatic venous outflow obstruction after piggyback liver transplantation
Wang, S. L., Sze, D. Y., Busque, S., Razavi, M. K., Kee, S. T., Frisoli, J. K., & Dake, M. D. (2005). Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. RADIOLOGY, 236(1), 352–59. -
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion
White, M., Haddad, H., Leblanc, M. H., Giannetti, N., Pflugfelder, P., Davies, R., … Ross, H. (2005). Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 24(7), 798–809. -
Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia
Greenstein, J., Guest, S., Tan, J. C., Tummala, P., Busque, S., & Rabkin, R. (2006). Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia. JOURNAL OF RENAL NUTRITION, 16(2), 141–49. -
Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid cross-sectional/angiographic imaging
Sze, D. Y., Strobel, N., Fahrig, R., Moore, T., Busque, S., & Frisoli, J. K. (2006). Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid cross-sectional/angiographic imaging. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 17(4), 711–15. -
Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation
Ma, I. W. Y., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D. C., Alfrey, E. J., … Scandling, J. D. (2006). Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. CLINICAL TRANSPLANTATION, 20(2), 139–46. -
Once-daily tacrolimus extended release formulation: Experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients
Florman, S., Alloway, R., Kalayoglu, M., Punch, J., Bak, T., Melancon, J., … First, M. R. (2007). Once-daily tacrolimus extended release formulation: Experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. TRANSPLANTATION, 83(12), 1639–1642. -
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study
Rush, D., Arlen, D., Boucher, A., Busque, S., Cockfield, S. M., Girardin, C., … Yilmaz, S. (2007). Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study. AMERICAN JOURNAL OF TRANSPLANTATION, 7(11), 2538–2545. -
Tolerance and chimerism after renal and hematopoietic-cell transplantation.
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., Shizuru, J. A., … Strober, S. (2008). Tolerance and chimerism after renal and hematopoietic-cell transplantation. New England Journal of Medicine, 358(4), 362–68. -
Islet cell survival during isolation improved through protein kinase C epsilon activation
Kvezereli, M., Vallentin, A., Mochly-Rosen, D., Busque, S., & Fontaine, M. J. (2008). Islet cell survival during isolation improved through protein kinase C epsilon activation. TRANSPLANTATION PROCEEDINGS, 40(2), 375–78. -
Glomerular Function, Structure, and Number in Renal Allografts from Older Deceased Donors
Tan, J. C., Workeneh, B., Busque, S., Blouch, K., Derby, G., & Myers, B. D. (2009). Glomerular Function, Structure, and Number in Renal Allografts from Older Deceased Donors. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 20(1), 181–88. -
Asynchronous, Out-of-Sequence, Transcontinental Chain Kidney Transplantation: A Novel Concept
Butt, F. K., Gritsch, H. A., Schulam, P., Danovitch, G. M., Wilkinson, A., Del Pizzo, J., … Veale, J. L. (2009). Asynchronous, Out-of-Sequence, Transcontinental Chain Kidney Transplantation: A Novel Concept. AMERICAN JOURNAL OF TRANSPLANTATION, 9(9), 2180–85. -
Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients
Busque, S., Leventhal, J., Brennan, D. C., Steinberg, S., Klintmalm, G., Shah, T., … Chan, G. (2009). Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 9(8), 1936–45. -
Factors Associated With Progression of Interstitial Fibrosis in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil
Rush, D. N., Cockfield, S. M., Nickerson, P. W., Arlen, D. J., Boucher, A., Busque, S., … Yilmaz, S. (2009). Factors Associated With Progression of Interstitial Fibrosis in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil. TRANSPLANTATION, 88(7), 897–903. -
Imprecision of Creatinine-Based GFR Estimates in Uninephric Kidney Donors
Tan, J. C., Ho, B., Busque, S., Blouch, K., Derby, G., Efron, B., & Myers, B. D. (2010). Imprecision of Creatinine-Based GFR Estimates in Uninephric Kidney Donors. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(3), 497–502. -
Effects of aging on glomerular function and number in living kidney donors
Tan, J. C., Busque, S., Workeneh, B., Ho, B., Derby, G., Blouch, K. L., … Myers, B. D. (2010). Effects of aging on glomerular function and number in living kidney donors. KIDNEY INTERNATIONAL, 78(7), 686–92. -
Population Pharmacokinetic Analysis of Mycophenolic Acid Coadministered With Either Tasocitinib (CP-690,550) or Tacrolimus in Adult Renal Allograft Recipients
Lamba, M., Tafti, B., Melcher, M., Chan, G., Krishnaswami, S., & Busque, S. (2010). Population Pharmacokinetic Analysis of Mycophenolic Acid Coadministered With Either Tasocitinib (CP-690,550) or Tacrolimus in Adult Renal Allograft Recipients. THERAPEUTIC DRUG MONITORING, 32(6), 778–81. -
Living donor evaluation and exclusion: the Stanford experience
Lapasia, J. B., Kong, S.-yee, Busque, S., Scandling, J. D., Chertow, G. M., & Tan, J. C. (2011). Living donor evaluation and exclusion: the Stanford experience. CLINICAL TRANSPLANTATION, 25(5), 697–704. -
C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation
Yabu, J. M., Higgins, J. P., Chen, G., Sequeira, F., Busque, S., & Tyan, D. B. (2011). C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation. TRANSPLANTATION, 91(3), 342–47. -
Managing Finances of Shipping Living Donor Kidneys for Donor Exchanges
Mast, D. A., Vaughan, W., Busque, S., VEALE, J. L., Roberts, J. P., Straube, B. M., … Melcher, M. L. (2011). Managing Finances of Shipping Living Donor Kidneys for Donor Exchanges. AMERICAN JOURNAL OF TRANSPLANTATION, 11(9), 1810–14. -
The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation
Busque, S., Cantarovich, M., Mulgaonkar, S., Gaston, R., Gaber, A. O., Mayo, P. R., … Meier-Kriesche, H.-U. (2011). The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 11(12), 2675–84. -
Induced Immune Tolerance for Kidney Transplantation
Scandling, J. D., Busque, S., Shizuru, J. A., Engleman, E. G., & Strober, S. (2011). Induced Immune Tolerance for Kidney Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 365(14), 1359–60. -
Validity of Surrogate Measures for Functional Nephron Mass
Tan, J. C., Paik, J., Chertow, G. M., Grumet, F. C., Busque, S., Lapasia, J., & Desai, M. (2011). Validity of Surrogate Measures for Functional Nephron Mass. TRANSPLANTATION, 92(12), 1335–41. -
Incidental kidney stones: a single center experience with kidney donor selection
Kim, I. K., Tan, J. C., Lapasia, J., Elihu, A., Busque, S., & Melcher, M. L. (2012). Incidental kidney stones: a single center experience with kidney donor selection. CLINICAL TRANSPLANTATION, 26(4), 558–63. -
Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Sarwal, M., Millan, M. T., … Strober, S. (2012). Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 12(5), 1133–45. -
Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year
Vincenti, F., Silva, H. T., Busque, S., O'Connell, P., Friedewald, J., Cibrik, D., … Chan, G. (2012). Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year. AMERICAN JOURNAL OF TRANSPLANTATION, 12(9), 2446–2456. -
Chain Transplantation: Initial Experience of a Large Multicenter Program
Melcher, M. L., Leeser, D. B., Gritsch, H. A., Milner, J., Kapur, S., Busque, S., … VEALE, J. L. (2012). Chain Transplantation: Initial Experience of a Large Multicenter Program. AMERICAN JOURNAL OF TRANSPLANTATION, 12(9), 2429–36. -
Desensitization Combined With Paired Exchange Leads to Successful Transplantation in Highly Sensitized Kidney Transplant Recipients: Strategy and Report of Five Cases
Yabu, J. M., Pando, M. J., Busque, S., & Melcher, M. L. (2013). Desensitization Combined With Paired Exchange Leads to Successful Transplantation in Highly Sensitized Kidney Transplant Recipients: Strategy and Report of Five Cases. TRANSPLANTATION PROCEEDINGS, 45(1), 82–87. -
Evaluating Deceased Donor Registries: Identifying Predictive Factors of Donor Designation
Hajhosseini, B., Stewart, B., Tan, J. C., Busque, S., & Melcher, M. L. (2013). Evaluating Deceased Donor Registries: Identifying Predictive Factors of Donor Designation. AMERICAN SURGEON, 79(3), 235–41. -
A Preconditioning Regimen With a PKC epsilon Activator Improves Islet Graft Function in a Mouse Transplant Model
Hamilton, D., Rugg, C., Davis, N., Kvezereli, M., Tafti, B. A., Busque, S., & Fontaine, M. (2014). A Preconditioning Regimen With a PKC epsilon Activator Improves Islet Graft Function in a Mouse Transplant Model. CELL TRANSPLANTATION, 23(7), 913–19. -
SIMULTANEOUS LIVER AND WHOLE PANCREAS HARVESTING IN THE MULTIORGAN CADAVERIC DONOR
Corman, J., Daloze, P., Smeesters, C., Aboujaoude, M., Busque, S., STLOUIS, G., & Beauregard, H. (1990). SIMULTANEOUS LIVER AND WHOLE PANCREAS HARVESTING IN THE MULTIORGAN CADAVERIC DONOR. CANADIAN JOURNAL OF SURGERY, 33(4), 277–281. -
CYCLOSPORINE AND THE REVERSIBILITY OF CHRONIC VASCULAR REJECTION
Guttmann, R. D., Forbes, R. D. C., Zheng, S., & Busque, S. (1994). CYCLOSPORINE AND THE REVERSIBILITY OF CHRONIC VASCULAR REJECTION. TRANSPLANTATION PROCEEDINGS, 26(5), 2564–2566. -
PASSENGER LEUKOCYTE EFFECT NOT MEDIATED BY INTERSTITIAL DENDRITIC CELLS
Guttmann, R. D., Forbes, R. D. C., Busque, S., Zheng, S., ALSAFFAR, M., & Colle, E. (1993). PASSENGER LEUKOCYTE EFFECT NOT MEDIATED BY INTERSTITIAL DENDRITIC CELLS. TRANSPLANTATION PROCEEDINGS, 25(1), 98–98. -
Primary liver transplantation without transfusion of red blood cells
Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Chuljian, P., Busque, S., … Esquivel, C. O. (1996). Primary liver transplantation without transfusion of red blood cells. SURGERY, 120(4), 698–704. -
Induction of long-term small bowel graft survival by low-dose immunosuppression in tolerized recipient rats
Chen, H., Xu, D., Qi, S., Busque, S., Tan, A., & Daloze, P. (1997). Induction of long-term small bowel graft survival by low-dose immunosuppression in tolerized recipient rats. TRANSPLANTATION PROCEEDINGS, 29(1-2), 697–698. -
Left hepaticogastrostomy for biliary obstruction: Long-term results
Soulez, G., Therasse, E., Oliva, V. L., Pomp, A., Busque, S., Dagenais, M., … Gagner, M. (1997). Left hepaticogastrostomy for biliary obstruction: Long-term results. RADIOLOGY, 204(3), 780–786. -
Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat
Vu, M. D., Qi, S. J., Xu, D. S., Wu, J. P., Fitzsimmons, W. E., Sehgal, S. N., … Chen, H. F. (1997). Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. TRANSPLANTATION, 64(12), 1853–1856. -
Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation
Busque, S., Esquivel, C. O., Concepcion, W., & So, S. K. S. (1998). Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. TRANSPLANTATION, 65(1), 77–82. -
Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat
Chen, H., Qi, S., Xu, D., Wu, J., Busque, S., & Daloze, P. (1998). Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat. TRANSPLANTATION PROCEEDINGS, 30(4), 1049–1050. -
Conversion from neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis
Busque, S., Demers, P., St-Louis, G., Boily, J. G., Tousignant, J., Lemieux, F., … Daloze, P. (1998). Conversion from neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. TRANSPLANTATION PROCEEDINGS, 30(4), 1247–1248. -
Intra-hepatic glutathione and oxidative stress in liver transplantation in the pig.
Yandza, T., Manika, A., Huynh, T., Lavoie, J. C., Champagne, J., Lepage, G., … Proulx, F. (1997). Intra-hepatic glutathione and oxidative stress in liver transplantation in the pig. ANNALES DE CHIRURGIE, 51(8), 839–844. -
Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation
Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Busque, S., Concepcion, W., … Esquivel, C. O. (1999). Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. ARCHIVES OF SURGERY, 134(1), 25–29. -
Uniform Long-Term Graft Survival in a Clincial Trial of the Induction of Tolerance to Kidney Transplants.
Scandling, J., Busque, S., Shori, A., Dejbakhsh-Jones, S., Shizuru, J., Lowsky, R., … Strober, S. (2013). Uniform Long-Term Graft Survival in a Clincial Trial of the Induction of Tolerance to Kidney Transplants. Presented at the 13th American Transplant Congress (ATC), SEATTLE,WA,WA,WA: WILEY-BLACKWELL. -
Donor renal cortical volumes and 6-month graft function in living donor transplantation.
Yan, J., Busque, S., Myers, B. D., & Tan, J. C. (2005). Donor renal cortical volumes and 6-month graft function in living donor transplantation. Presented at the 6th American Transplant Congress, SEATTLE,WA,WA,WA,WA,WA: WILEY-BLACKWELL. -
Donors with Kidney Stones: Should We Pass?
Kim, I. K., Lapasia, J., Elihu, A., Tan, J., Scandling, J., Busque, S., & Melcher, M. (2011). Donors with Kidney Stones: Should We Pass? Presented at the Congress of the American-Society-of-Transplant-Surgeons, SAN DIEGO,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL PUBLISHING, INC. -
Post kidney transplantation weight gain is not associated with steroid usage
Yan, J., Scandling, Y., Busque, S., & Tan, J. C. (2005). Post kidney transplantation weight gain is not associated with steroid usage. Presented at the 6th American Transplant Congress, SEATTLE,WA,WA,WA,WA,WA: WILEY-BLACKWELL. -
Pre-operative MRI kidney volumes as a predictor of graft function in living donor kidney transplantation.
Bhatt, A., Arjane, P., Busque, S., & Tan, J. C. (2003). Pre-operative MRI kidney volumes as a predictor of graft function in living donor kidney transplantation. Presented at the 36th Annual Meeting of the American-Society-of-Nephrology, SAN DIEGO,CA,CA,CA,CA,CA,CA: AMER SOC NEPHROLOGY. -
Effect of steroid avoidance on early graft function after kidney transplantation
Roozrokh, H. C., Chen, L., Scandling, J. D., Momsen, A., Tan, J., & Busque, S. (2004). Effect of steroid avoidance on early graft function after kidney transplantation. Presented at the 5th American Transplant Congress, BOSTON,MA: WILEY-BLACKWELL. -
Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation.
Scandling, J. D., Busque, S., Shizuru, J. A., Lowsky, R., Hoppe, R., Dejbakhsh-Jones, S., … Strober, S. (2015). Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation. American Journal of Transplantation , 15(3), 695–704. -
Longitudinal study of living kidney donor glomerular dynamics after nephrectomy
Lenihan, C. R., Busque, S., Derby, G., Blouch, K., Myers, B. D., & Tan, J. C. (2015). Longitudinal study of living kidney donor glomerular dynamics after nephrectomy. JOURNAL OF CLINICAL INVESTIGATION, 125(3), 1311–1318. -
The Association of Predonation Hypertension with Glomerular Function and Number in Older Living Kidney Donors
Lenihan, C. R., Busque, S., Derby, G., Blouch, K., Myers, B. D., & Tan, J. C. (2015). The Association of Predonation Hypertension with Glomerular Function and Number in Older Living Kidney Donors. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26(6), 1261–67. -
Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients
Vincenti, F., Silva, H. T., Busque, S., O'Connell, P. J., Russ, G., Budde, K., … Chan, G. (2015). Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients. AMERICAN JOURNAL OF TRANSPLANTATION, 15(6), 1644–53. -
Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., Shizuru, J. A., … Strober, S. (2008). Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 358(4), 362–68. -
Regression of hypertrichosis and gingival hypertrophy in renal transplant recipients following replacement of cyclosporin by tracrolimus.
Busque, S., Demers, P., Saint-Louis, G., Boily, J. G., Tousignant, J., Lemieux, F., … Daloze, P. (1999). Regression of hypertrichosis and gingival hypertrophy in renal transplant recipients following replacement of cyclosporin by tracrolimus. ANNALES DE CHIRURGIE, 53(8), 687–689. -
Macrochimerism and clinical transplant tolerance.
Scandling, J. D., Busque, S., Lowsky, R., Shizuru, J., Shori, A., Engleman, E., … Strober, S. (2018). Macrochimerism and clinical transplant tolerance. Human Immunology. -
Effects of Hypertension On Glomerular Function and Number in Living Kidney Donors.
Lenihan, C., Busque, S., Myers, B., & Tan, J. (2014). Effects of Hypertension On Glomerular Function and Number in Living Kidney Donors. TRANSPLANTATION, 98, 483. -
Relationship Between Mixed Chimerism and Tolerance in HLA-Matched and -Mismatched Recipients of Kidney and Hematopoietic Cell Transplants
Busque, S., Scandling, J., Shizuru, J., Lowsky, R., Shori, A., Kent, J., … Strober, S. (2017). Relationship Between Mixed Chimerism and Tolerance in HLA-Matched and -Mismatched Recipients of Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 17, 276. -
Resolution of Acute Kidney Injury After Liver Transplantation: A Single Center Experience.
Todo, T., Gallo, A., Berumen, J., Feinberg, E., Melcher, M., Bonham, C., … Esquivel, C. (2014). Resolution of Acute Kidney Injury After Liver Transplantation: A Single Center Experience. AMERICAN JOURNAL OF TRANSPLANTATION, 14, 759. -
The Long Term Follow Up of Aging Kidney Donors
Lenihan, C., Busque, S., Myers, B., & Tan, J. (2014). The Long Term Follow Up of Aging Kidney Donors. AMERICAN JOURNAL OF TRANSPLANTATION, 14, 489–90. -
Resolution of Acute Kidney Injury after Liver Transplantation: Single Center Experience
Todo, T., Gallo, A., Beruman, J., Feinberg, E., Melcher, M., Bonham, C., … Esquivel, C. (2014). Resolution of Acute Kidney Injury after Liver Transplantation: Single Center Experience. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY-BLACKWELL. -
A Cost Analysis of Tolerance Induction for Two-Haplotype Match Kidney Transplant Recipients
Erickson, K. F., Winkelmayer, W. C., Busque, S., Lowsky, R., Scandling, J. D., & Strober, S. (2016). A Cost Analysis of Tolerance Induction for Two-Haplotype Match Kidney Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 16(1), 371–73. -
The Long Term Follow Up of Aging Kidney Donors.
Lenihan, C., Busque, S., Myers, B., & Tan, J. (2014). The Long Term Follow Up of Aging Kidney Donors. TRANSPLANTATION, 98, 489–90. -
Identification of miRNAs Associated With Induced Tolerance to Allografts
Vitalone, M., Wei, L., Esquivel, C., Busque, S., Martinez, O., & Krams, S. (2015). Identification of miRNAs Associated With Induced Tolerance to Allografts. AMERICAN JOURNAL OF TRANSPLANTATION, 15. -
Stable and Unstable Chimerism During Immunosuppressive Drug Withdrawal in Tolerant Recipients of HLA Matched Combined Kidney and Hematopoietic Cell Transplants
Pham, T., Busque, S., Scandling, J., Shizuru, J., Asha, S., & Strober, S. (2015). Stable and Unstable Chimerism During Immunosuppressive Drug Withdrawal in Tolerant Recipients of HLA Matched Combined Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 15. -
Detection of coronary artery disease in kidney and/or pancreas transplant candidates with type I diabetes mellitus.
Ma, I. W., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D., Alfrey, E., … Scandling, J. D. (2002). Detection of coronary artery disease in kidney and/or pancreas transplant candidates with type I diabetes mellitus. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13, 192A. -
Early Excellent Outcomes of Flow Cross-Match Negative Kidney Transplant Recipients With Pre-Formed IgG DSA, C1q Negative With or Without Peri-Operative IVIg Infusion
Busque, S., Yabu, J., Melcher, M., Gallo, A., Kong, S., Makki, T., … Tyan, D. (2014). Early Excellent Outcomes of Flow Cross-Match Negative Kidney Transplant Recipients With Pre-Formed IgG DSA, C1q Negative With or Without Peri-Operative IVIg Infusion. AMERICAN JOURNAL OF TRANSPLANTATION, 14, 512. -
Adverse Events of Over-Immunosuppression Are Dependent on Tofacitinib Exposure in Kidney Transplant (KT) Patients.
Busque, S., Vincenti, F., Tedesco Silva, H., O'Connell, P., Tortorici, M., Lawendy, N., … Chan, G. (2013). Adverse Events of Over-Immunosuppression Are Dependent on Tofacitinib Exposure in Kidney Transplant (KT) Patients. AMERICAN JOURNAL OF TRANSPLANTATION, 13, 86. -
Resolution of Acute Kidney Injury After Liver Transplantation: A Single Center Experience.
Todo, T., Gallo, A., Berumen, J., Feinberg, E., Melcher, M., Bonham, C., … Esquivel, C. (2014). Resolution of Acute Kidney Injury After Liver Transplantation: A Single Center Experience. TRANSPLANTATION, 98, 759. -
Safety and Effectiveness of Valganciclovir for Cytomegalovirus Prophylaxis in Solid Organ Transplant Patients on Hemodialysis
Wang, U., Yang, A., Dong, M., & Busque, S. (2013). Safety and Effectiveness of Valganciclovir for Cytomegalovirus Prophylaxis in Solid Organ Transplant Patients on Hemodialysis. AMERICAN JOURNAL OF TRANSPLANTATION, 13, 212. -
EFFECT OF TOFACITINIB EXPOSURE ON OUTCOMES IN KIDNEY TRANSPLANT PATIENTS (KT PTS)
Vincenti, F., Tedesco-Silva, H., O'Connell, P., Busque, S., Tortorici, M., Hahn, C. M., … Chan, G. (2013). EFFECT OF TOFACITINIB EXPOSURE ON OUTCOMES IN KIDNEY TRANSPLANT PATIENTS (KT PTS). TRANSPLANT INTERNATIONAL, 26, 101. -
Tolerance, Mixed Chimerism, and Graft Survival in HLA Matched and Mismatched Recipients of Kidney and Hematopoietic Cell Transplants.
Scandling, J., Busque, S., Shizuru, J., Lowsky, R., Dejbakhsh-Jones, S., Jensen, K., … Strober, S. (2014). Tolerance, Mixed Chimerism, and Graft Survival in HLA Matched and Mismatched Recipients of Kidney and Hematopoietic Cell Transplants. TRANSPLANTATION, 98, 901. -
Early Excellent Outcomes of Flow Cross-Match Negative Kidney Transplant Recipients With Pre-Formed IgG DSA, C1q Negative With or Without Peri-Operative IVIg Infusion.
Busque, S., Yabu, J., Melcher, M., Gallo, A., Kong, S., Makki, T., … Tyan, D. (2014). Early Excellent Outcomes of Flow Cross-Match Negative Kidney Transplant Recipients With Pre-Formed IgG DSA, C1q Negative With or Without Peri-Operative IVIg Infusion. TRANSPLANTATION, 98, 512. -
A Decade'S Experience with Safety and Efficacy of Tolerance Induction in Clinical Kidney Transplantation
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Shori, A., Shizuru, J., … Strober, S. (2012). A Decade'S Experience with Safety and Efficacy of Tolerance Induction in Clinical Kidney Transplantation. TRANSPLANTATION, 94(10), 55. -
Tolerance, Mixed Chimerism, and Graft Survival in HLA Matched and Mismatched Recipients of Kidney and Hematopoietic Cell Transplants.
Scandling, J., Busque, S., Shizuru, J., Lowsky, R., Dejbakhsh-Jones, S., Jensen, K., … Strober, S. (2014). Tolerance, Mixed Chimerism, and Graft Survival in HLA Matched and Mismatched Recipients of Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 14, 901. -
Gene Array Pattern for Induced Human Kidney Transplant Tolerance with Safe Immunosuppression Withdrawal
Li, L., Hsieh, S., Lowsky, R., Busque, S., Scandling, J., Jones, S., … Sarwal, M. (2012). Gene Array Pattern for Induced Human Kidney Transplant Tolerance with Safe Immunosuppression Withdrawal. AMERICAN JOURNAL OF TRANSPLANTATION, 12, 183. -
Effects of Hypertension On Glomerular Function and Number in Living Kidney Donors.
Lenihan, C., Busque, S., Myers, B., & Tan, J. (2014). Effects of Hypertension On Glomerular Function and Number in Living Kidney Donors. AMERICAN JOURNAL OF TRANSPLANTATION, 14, 483. -
Improving pancreatic islet cell function and survival through PKC epsilon activation
Kvezereli, M., Alice, V., Mochly-Rosen, D., Busque, S., & Fontaine, M. J. (2007). Improving pancreatic islet cell function and survival through PKC epsilon activation. XENOTRANSPLANTATION, 14(5), 516–17. -
Relationship between Mixed Chimerism and Acceptance of HLA-Matched and Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs.
Scandling, J., Busque, S., Lowsky, R., Shizuru, J., Jensen, K., Shori, A., … Strober, S. (2018). Relationship between Mixed Chimerism and Acceptance of HLA-Matched and Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 470. -
Changes in Phenotype, Immune Suppressive, Function, and Gene Expression of Myeloid Derived Suppressor Cells in Patients Given Combined Kidney and Hematopoietic Cell Transplants in a Tolerance Protocol.
Jensen, K., Zheng, P., Xuhuai, J., Saraswathula, A., Scandling, J., Busque, S., … Strober, S. (2018). Changes in Phenotype, Immune Suppressive, Function, and Gene Expression of Myeloid Derived Suppressor Cells in Patients Given Combined Kidney and Hematopoietic Cell Transplants in a Tolerance Protocol. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 495–96. -
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
Busque, S., Vincenti, F. G., Silva, H. T., O'Connell, P. J., Yoshida, A., Friedewald, J. J., … Chan, G. (2018). Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial. TRANSPLANTATION DIRECT, 4(9). -
Native Kidney Cytomegalovirus Nephritis and Cytomegalovirus Prostatitis in a Kidney Transplant Recipient.
Tan, S. K., Cheng, X. S., Kao, C.-S., Weber, J., Pinsky, B. A., Gill, H. S., … Tan, J. C. (2018). Native Kidney Cytomegalovirus Nephritis and Cytomegalovirus Prostatitis in a Kidney Transplant Recipient. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e12998. -
A New Approach to Kidney Waitlist Management in the Kidney Allocation System Era: Pilot Implementation and Evaluation.
Cheng, X. S., Busque, S., Lee, J., Discipulo, K., Hartley, C., Tulu, Z., … Tan, J. C. (2018). A New Approach to Kidney Waitlist Management in the Kidney Allocation System Era: Pilot Implementation and Evaluation. Clinical Transplantation, e13406. -
A NOVEL FLOW CYTOMETRIC ASSAY TO SIMULTANEOUSLY DETECT ATG CONCENTRATION AND CYTOTOXIC EFFECT IN RENAL TRANSPLANT PATIENT
Chen, G., Lin, L., Busque, S., & Vina, M. A. F. (2018). A NOVEL FLOW CYTOMETRIC ASSAY TO SIMULTANEOUSLY DETECT ATG CONCENTRATION AND CYTOTOXIC EFFECT IN RENAL TRANSPLANT PATIENT. HUMAN IMMUNOLOGY, 79, 135–36. -
Relationship Between Mixed Chimerism and Acceptance of HLA-matched and -Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs
Busque, S., Scandling, J., Lowsky, R., Shizuru, J., Jensen, K., Shori, A., … Strober, S. (2018). Relationship Between Mixed Chimerism and Acceptance of HLA-matched and -Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs. TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS. -
Improved Short-Term Survival in HCV Seropositive Kidney Transplant Recipients during the Daa Era in the United States
Wong, K., Cholankeril, G., Gadiparthi, C., Somasundar, P., Busque, S., Esquivel, C. O., & Ahmed, A. (2018). Improved Short-Term Survival in HCV Seropositive Kidney Transplant Recipients during the Daa Era in the United States. HEPATOLOGY. WILEY. -
Combined Deceased Donor Parathyroid and Kidney Transplantation - An Underutilized Approach for ESRD Patients with Permanent Hypoparathyroidism
Lee, L.-Y., Pan, J., Vasa, P., Berry, G., Lenihan, C., & Busque, S. (2019). Combined Deceased Donor Parathyroid and Kidney Transplantation - An Underutilized Approach for ESRD Patients with Permanent Hypoparathyroidism. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY. -
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial.
Busque, S., Vincenti, F. G., Tedesco Silva, H., O'Connell, P. J., Yoshida, A., Friedewald, J. J., … Chan, G. (2018). Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial. Transplantation Direct, 4(9), e380. -
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant.
Redfield, R. R., Jordan, S. C., Busque, S., Vincenti, F., Woodle, E. S., Desai, N., … Borie, D. (2019). Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Persistent Mixed Chimerism, Immune Reconstitution, and Tolerance in Recipients of HLA Matched Kidney and Hematopoietic Cell Transplants.
Busque, S., Scandling, J., Lowsky, R., Shizuru, J., Meyer, E., Jensen, K., … Strober, S. (2019). Persistent Mixed Chimerism, Immune Reconstitution, and Tolerance in Recipients of HLA Matched Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 19, 348–49. -
IE-1 Specific T Cell Receptor Repertoire Diversity and Protection against CMV Reactivation.
Perez, M. L., Rubelt, F., Busque, S., Esquivel, C. O., Krams, S. M., Bestard, O., & Martinez, O. M. (2019). IE-1 Specific T Cell Receptor Repertoire Diversity and Protection against CMV Reactivation. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY. -
Impact of Immunosuppressive Drug Withdrawal on Persistent Mixed Chimerism in Recipients of HLA Haplo-Identical Kidney and Hematopoietic Cell Transplants.
Busque, S., Scandling, J., Lowsky, R., Shizuru, J., Meyer, E., Jensen, K., … Strober, S. (2019). Impact of Immunosuppressive Drug Withdrawal on Persistent Mixed Chimerism in Recipients of HLA Haplo-Identical Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 19, 348. -
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.
Busque, S., Scandling, J. D., Lowsky, R., Shizuru, J., Jensen, K., Waters, J., … Strober, S. (2020). Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal. Science Translational Medicine, 12(528). -
Influence of Immunosuppression on Seroconversion Against SARS-Cov-2 in Two Kidney Transplant Recipients.
Wang, A. X., Quintero Cardona, O., Ho, D. Y., Busque, S., & Lenihan, C. R. (2020). Influence of Immunosuppression on Seroconversion Against SARS-Cov-2 in Two Kidney Transplant Recipients. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e13423. -
Single Dose Rituximab and Anti-Thymocyte Globulin (ATG) Induction in Hypersensitized Kidney Transplant Recipients
Wang, A. X., Wang, U., Busque, S., & Lenihan, C. R. (2020). Single Dose Rituximab and Anti-Thymocyte Globulin (ATG) Induction in Hypersensitized Kidney Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY. -
Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients.
Jensen, K. P., Hongo, D., Ji, X., Zheng, P., Pawar, R. D., Wu, H.-H., … Strober, S. (2021). Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients. Blood Advances. -
MDR-101-MLK-MERCURY Kidney Transplant Tolerance Study Update
Kaufman, D., Akkina, S., Stegall, M., Piper, J., Gaber, A. O., Marin, E., … Brennan, D. (2021). MDR-101-MLK-MERCURY Kidney Transplant Tolerance Study Update. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY. -
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017.
Cheng, X. S., Han, J., Braggs-Gresham, J. L., Held, P. J., Busque, S., Roberts, J. P., … Dor, A. (2022). Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017. JAMA Network Open, 5(3), e221847. -
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.
Wang, A. X., Busque, S., Kuo, J., Singh, U., Roeltgen, K., Pinsky, B. A., … Lenihan, C. R. (2022). SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients. Kidney360, 3(1), 133–143. -
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study.
Yang, L. M., Costales, C., Ramanathan, M., Bulterys, P. L., Murugesan, K., Schroers-Martin, J., … Banaei, N. (2022). Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study. Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 153, 105217. -
Allocation Based on Acuity Circles: Effects on Pediatric Liver Allocation.
Kim, M., Kim, M. H., Gallo, A., Pham, T., Melcher, M. L., Busque, S., … Bonham, C. (2022). Allocation Based on Acuity Circles: Effects on Pediatric Liver Allocation. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY. -
Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol.
Scandling, J. D., Busque, S., Lowsky, R., Pham, T., Hoppe, R., Jensen, K., … Strober, S. (2022). Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY. -
Allocation Based on Acuity Circles Decreases Waiting Time for Liver Transplant Patients.
Kim, M. H., Sasaki, K., Gallo, A., Pham, T., Melcher, M. L., Busque, S., … Bonham, C. (2022). Allocation Based on Acuity Circles Decreases Waiting Time for Liver Transplant Patients. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY. -
Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients.
Looney, C. M., Schroeder, A., Tavares, E., Garg, J., Schindler, T., Vincenti, F., … Morimoto, A. (2023). Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients. Transplantation Direct, 9(2), e1436. -
Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol
Scandling, J., Busque, S., Lowsky, R., Pham, T., Hoppe, R., Jensen, K., … Strober, S. (2022). Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol. TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS. -
IDENTIFYING NOVEL GENE TARGETS FOR DIAGNOSIS AND TREATEMENT OF HCC IN ASIAN AND CAUCASIAN POPULATIONS BASED ON WHOLE GENOME SEQUENCING
Hong, S., Badshah, J., Aliwaisi, A., Sasaki, K., Pruett, T., Melcher, M., … Kirchner, V. (2023). IDENTIFYING NOVEL GENE TARGETS FOR DIAGNOSIS AND TREATEMENT OF HCC IN ASIAN AND CAUCASIAN POPULATIONS BASED ON WHOLE GENOME SEQUENCING. AMERICAN JOURNAL OF TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Defining tumor-associated macrophages subpopulation in intrahepatic cholangiocarcinoma as prognostic and therapeutic targets
Badshah, J., Aliwaisi, A., Subramanian, S., Hong, S., Teavir, W., Sasaki, K., … Kirchner, V. (2023). Defining tumor-associated macrophages subpopulation in intrahepatic cholangiocarcinoma as prognostic and therapeutic targets. TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS. -
Addition of a Single Low Dose of Total Body Irradiation (tbi) to a Total Lymphoid Irradiation (tli) and Anti-Thymocyte Globulin (atg) Conditioning Regimen Improves Mixed Hematopoietic Engraftment in a Tolerance Induction Protocol After Hla-Haplo-Matched (hhm) Living Donor Kidney Transplantation
Busque, S., Scandling, J., Lowsky, R., Pham, T., Hoppe, R., Jensen, K., … Strober, S. (2023). Addition of a Single Low Dose of Total Body Irradiation (tbi) to a Total Lymphoid Irradiation (tli) and Anti-Thymocyte Globulin (atg) Conditioning Regimen Improves Mixed Hematopoietic Engraftment in a Tolerance Induction Protocol After Hla-Haplo-Matched (hhm) Living Donor Kidney Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. ELSEVIER SCIENCE INC. -
The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation.
Xu, K., Dor, A., Mohanty, S., Han, J., Parvathinathan, G., Braggs-Gresham, J. L., … Cheng, X. S. (2024). The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation. Medical Care. -
Nested Semi-Transparent Isosurface Simulated Volume-Rendering (NESTIS-VR) - An efficient on-device rendering approach for Augmented Reality headsets increasing surgeon confidence of kidney donor arterial anatomy.
Necker, F. N., Melcher, M. L., Busque, S., Leuze, C. W., Ghanouni, P., Le Castillo, C., … Daniel, B. L. (2024). Nested Semi-Transparent Isosurface Simulated Volume-Rendering (NESTIS-VR) - An efficient on-device rendering approach for Augmented Reality headsets increasing surgeon confidence of kidney donor arterial anatomy. Computers in Biology and Medicine, 183, 109267. -
Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance.
Stark, H., Ho, Q. Y., Cross, A., Alessandrini, A., Bertaina, A., Brennan, D., … Issa, F. (2025). Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance. Transplantation. -
Induction of Immune Tolerance in Living Related HLA-Matched Kidney Transplantation: A Phase 3 Randomized Clinical Trial.
Kaufman, D. B., Akkina, S. K., Stegall, M. D., Piper, J. B., Gaber, A. O., Asch, W. S., … Brennan, D. C. (2025). Induction of Immune Tolerance in Living Related HLA-Matched Kidney Transplantation: A Phase 3 Randomized Clinical Trial. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF).
Kowli, S., Minocherhomji, S., Martinez, O. M., Busque, S., Lebrec, H., & Maecker, H. T. (2025). Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF). ImmunoHorizons, 9(4). -
Advocating for collaboration among key partners to promote diversity in clinical studiesÌýamid policy challenges in the United States of America.
Byiringiro, S., Garcia, J. K., Farrell, N., Ogungbe, B., Barsha, R. A., Miller, H. N., … Valantine, H. (2025). Advocating for collaboration among key partners to promote diversity in clinical studiesÌýamid policy challenges in the United States of America. Trials, 26(1), 117. -
Donor-Targeted Anti-HLA-A2 Antibody Shows Nanogram-Level Efficacy in a Novel GVHD Mouse Model.
Niizuma, K., Chang, A. H., Kim, J. S., Busque, S., Majeti, R., Nakauchi, H., & Nakauchi, Y. (2025). Donor-Targeted Anti-HLA-A2 Antibody Shows Nanogram-Level Efficacy in a Novel GVHD Mouse Model. BioRxiv : the Preprint Server for Biology. -
A Modified Tolerance Induction Regimen Incorporating Total Lymphoid Irradiation, Anti-Thymocyte Globulin, and Low-Dose Total Body Irradiation Achieves Sustained Mixed Chimerism and Immunosuppression Withdrawal or Minimization to Mycophenolate Mofetil in Haplotype-Matched Kidney Transplant Recipients
Busque, S., Meyer, E., Scandling, J., Pham, T., Hoppe, R., Sheehan, K., … Lowsky, R. (2025). A Modified Tolerance Induction Regimen Incorporating Total Lymphoid Irradiation, Anti-Thymocyte Globulin, and Low-Dose Total Body Irradiation Achieves Sustained Mixed Chimerism and Immunosuppression Withdrawal or Minimization to Mycophenolate Mofetil in Haplotype-Matched Kidney Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION. ELSEVIER SCIENCE INC.
-
In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil
Clinical Trials
Clinical trials are À¶Ý®ÊÓƵ studies that evaluate a new medical approach, device, drug, or other treatment. As a À¶Ý®ÊÓƵ patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
- Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.
- Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation
- Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
Practice Locations
Kidney and Pancreas Transplant Program Palo Alto, CA
Palo Alto, CA
Kidney and Pancreas Transplant Program
300 Pasteur Dr, Fl 1 Ste A160
Palo Alto , CA 94305
Make An Appointment More Clinic Information Getting HereLiver Transplant Program at Boswell Building Palo Alto, CA
Palo Alto, CA
Liver Transplant Program at Boswell Building
300 Pasteur Dr
Palo Alto , CA 94305
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
À¶Ý®ÊÓƵ, À¶Ý®ÊÓƵ Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by À¶Ý®ÊÓƵ, À¶Ý®ÊÓƵ Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of À¶Ý®ÊÓƵ, À¶Ý®ÊÓƵ Tri- Valley, or Stanford Medicine Partners. À¶Ý®ÊÓƵ, À¶Ý®ÊÓƵ Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(32 reviews)
The best. Explain everything well. Very concerned for patient.
Treat very well.
Very understanding and caring doctor. Dr. Busque/Dr. Pham/Dr. Gray
Dr. Busque is the best!
All the personnel very attentive.
Good experience.
Good very good.
Dr. Busque is an amazing surgeon and person. His confidence flows over to me. Everything was very well explained. We appreciate all he has done both for me and my donor wife.
À¶Ý®ÊÓƵ were very informative, great bedside manner.
Did explain everything to me perfectly & even did drawings for me demonstrating to me how everything was.
Highly helpful and approachable during all visits exceeded my expectations with the care for the patient.
Dr. Busque has been amazing! Always explains everything well. Enjoy his humor.
Dr. Busque was awesome spend a solid hour talking about transplant options and he was very kind, I trust him & his opinion very much, felt lucky to have him share knowledge with us.
Dr. Busque is excellent! Always!
The first time I met Dr. Busque I had the confidence that I had the best surgeon for my surgery. I felt at ease.
Dr. Busque & all his team of drs, nurses are of the best in professionalism kindness & confidence in the medical camp.
Excellent.
Wonderful doctor!!
Dr. Busque is educational and very friendly. He answered all my questions.
Dr. Busque is the best!! My all time favorite!!
Dr Busque is more than excellent. great demeanor, professional, informative. there aren't enough adjectives to describe this person. miracle worker
Very good doctor, very kind and respectful.
As always the team is very courteous and friendly. I am honored to have them be my doctors & staff.
Excellent doctor very kind & courteous, I would recommend Stanford to all the people, as the best hospital, of said an acquaintance already was attended there.
So much helpful info. All questions answered.
Stephan Busque, MD is a superb doctor and physician. I have recommended him and will continue to do so.
Dr. Busque & Dr. Scandling & staff are the best. Can't ask for more.
Dr. Busque was awesome!! He was very easy to talk to and had a great demeanor!
Excellent
None. Always happy and satisfied.
Excellent care provider.
Good.
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Phone:Ìý1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
À¶Ý®ÊÓƵ provides comprehensive services toÌýreferÌýandÌýtrack patients, as well as the latest information and news for physicians and office staff.ÌýFor help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
Ìý
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records